The IN.PACT AV Access study, recently published in the New England Journal of Medicine (NEJM), showed that drug-coated balloons are superior for the treatment of stenotic lesions in arteriovenous fistulas for dialysis compared with conventional balloons. Dialysis fistulas are an unknown territory for paclitaxel-eluting balloons, since the formal recommendation in the guidelines is conventional angioplasty<a href="https://solaci.org/en/2020/09/30/in-pact-av-access-drug-coated-balloons-for-dialysis-fistulas/" title="Read more" >...</a>
Is the Paradigm for Bifurcation Lesions Changing Once More?
Four years ago, we published a summary of the SMART-STRATEGY Study saying that, with bifurcation lesions, “less is more.” Last month, the DEFINITION Study published in the European Heart Journal suggested that things were about to change. Today, the DK-crush technique seems to have rendered both title and article obsolete. According to this recent analysis<a href="https://solaci.org/en/2020/08/31/is-the-paradigm-for-bifurcation-lesions-changing-once-more/" title="Read more" >...</a>
SOLACI PERIPHERAL | 3rd Clinical Case: Femoral PCI
In keeping with its Clinical Case Discussion Program, SOLACI’s peripheral interventions department, SOLACI Peripheral, presents the third clinical case, to promote knowledge exchange across the entire Latin American hemodynamics community. Share your thoughts on case and resolution in the comments and answer the questions at the end of the article. Femoral PCI Authors: MD Mauricio Cavalieri<a href="https://solaci.org/en/2020/08/24/solaci-peripheral-3rd-clinical-case-femoral-pci/" title="Read more" >...</a>
Impact on Mortality with Rivaroxaban after Discharge
Extending thromboembolic prophylaxis with rivaroxaban in patients hospitalized for heart conditions reduce fatal and thromboembolic events by 28% without major bleeding payback. Patients hospitalized for heart conditions are at risk of thromboembolic events, and this is why inhospital prophylaxis (in general with low molecular weight heparin) is within the standard treatment. It was not<a href="https://solaci.org/en/2020/08/14/impact-on-mortality-with-rivaroxaban-after-discharge/" title="Read more" >...</a>
Is Medical Treatment Better at Lowering Bleeding-Caused Mortality than Angioplasty?
Post-discharge bleeding in patients admitted for acute coronary syndrome (ACS) is linked to higher all-cause mortality. However, this is the case for both patients who underwent angioplasty and those who were managed with medical treatment. These are interesting data, given that medical treatment is frequently preferred due to lower bleeding risk. Speculation is based on<a href="https://solaci.org/en/2020/08/12/is-medical-treatment-better-at-lowering-bleeding-caused-mortality-than-angioplasty/" title="Read more" >...</a>
The Most Read Scientific Articles of July in Interventional Cardiology
01- SOLACI PERIPHERAL | 2nd Clinical Case: Juxtarenal Abdominal Aortic Aneurysm SOLACI’s Department of Peripheral Endovascular Interventions brings a new challenging clinical case for the whole Latin American medical community so as to continue fostering and sharing scientific knowledge and experience among peers. Read more HERE 02- EuroPCR 2020 | A Trick to Find the Perfect<a href="https://solaci.org/en/2020/08/10/the-most-read-scientific-articles-of-july-in-interventional-cardiology/" title="Read more" >...</a>
ISAR-TEST-5: 10 años de los DES con polímero vs sin polímero
After 10 years, unstable or chronic coronary patients revascularized with drug-eluting stents (DES) had similar, very good outcomes regardless of whether the DES did or did not have a polymer, according to the ISAR-TEST-5 study, recently published in J Am Coll Cardiol. The 10-year device-oriented endpoints occurred in 43.8% of patients treated with a polymer-free sirolimus-eluting<a href="https://solaci.org/en/2020/07/30/isar-test-5-10-anos-de-los-des-con-polimero-vs-sin-polimero-2/" title="Read more" >...</a>
Two-Stent Strategy is Safer in True Bifurcation Lesions
Courtesy of Dr. Carlos Fava. DES have improved PCI outcomes, but one of its biggest challenges continues to be bifurcations (especially when we have to use two stents, since it’s been associated to higher restenosis and stent thrombosis rates). Left main coronary artery true bifurcation lesions are the ones that generate the greatest challenge and<a href="https://solaci.org/en/2020/07/28/two-stent-strategy-is-safer-in-true-bifurcation-lesions/" title="Read more" >...</a>
The Most Read Scientific Articles of June in solaci.org
01- The FDA Approves Ticagrelor for Primary Prevention in High Risk Patients The FDA has approved the indication of ticagrelor as primary prevention in high risk CAD patients with no history of MI or stroke. Read also HERE 02- Estimating the Risk of Infection for Healthcare Personnel Roughly one out of every 100 healthcare workers at<a href="https://solaci.org/en/2020/07/27/the-most-read-scientific-articles-of-june-in-solaci-org/" title="Read more" >...</a>
Randomized Evidence on the Helpfulness of Yoga for Cardiac Rehabilitation
This work brings us evidence that yoga-based cardiac rehabilitation improves how patients feel about their health and reduces the time it takes them to resume the activities they could perform before experiencing an infarction. That is important information with impeccable timing. The COVID-19 pandemic has interrupted most of the assistance we offer to cardiovascular patients,<a href="https://solaci.org/en/2020/07/24/randomized-evidence-on-the-helpfulness-of-yoga-for-cardiac-rehabilitation/" title="Read more" >...</a>